Pharmacology

Profiles, parameters, interpretations, and drug interactions

Gary C Yee, T. Rosano, R. Ptachcinski

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Although knowledge concerning CsA pharmacology has expanded since the last CsA Congress in 1983, many of the same questions remain and many new questions are being asked. Examples of the questions that have not been answered include 'what is the most appropriate biologic fluid (whole blood v serum/plasma) or assay method (HPLC v RIA) for monitoring CsA concentration?' With the advent of HPLC assays that can measure CsA metabolites in biologic fluids, new questions include 'do CsA metabolites contribute significantly to either immunosuppression or renal toxicity?' Or, 'what is the role of the newly introduced immunoassays?' It is encouraging to note the continued interest in CsA pharmacology. It is hoped that present and future studies will provide answers to some of these questions.

Original languageEnglish (US)
Pages (from-to)715-721
Number of pages7
JournalTransplantation Proceedings
Volume20
Issue number2 SUPPL. 2
StatePublished - Jan 1 1988

Fingerprint

Drug Interactions
High Pressure Liquid Chromatography
Pharmacology
Immunoassay
Immunosuppression
Kidney
Serum

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Pharmacology : Profiles, parameters, interpretations, and drug interactions. / Yee, Gary C; Rosano, T.; Ptachcinski, R.

In: Transplantation Proceedings, Vol. 20, No. 2 SUPPL. 2, 01.01.1988, p. 715-721.

Research output: Contribution to journalReview article

Yee, GC, Rosano, T & Ptachcinski, R 1988, 'Pharmacology: Profiles, parameters, interpretations, and drug interactions', Transplantation Proceedings, vol. 20, no. 2 SUPPL. 2, pp. 715-721.
Yee, Gary C ; Rosano, T. ; Ptachcinski, R. / Pharmacology : Profiles, parameters, interpretations, and drug interactions. In: Transplantation Proceedings. 1988 ; Vol. 20, No. 2 SUPPL. 2. pp. 715-721.
@article{f2fd008ab3d54cc987a69fb99752fdf3,
title = "Pharmacology: Profiles, parameters, interpretations, and drug interactions",
abstract = "Although knowledge concerning CsA pharmacology has expanded since the last CsA Congress in 1983, many of the same questions remain and many new questions are being asked. Examples of the questions that have not been answered include 'what is the most appropriate biologic fluid (whole blood v serum/plasma) or assay method (HPLC v RIA) for monitoring CsA concentration?' With the advent of HPLC assays that can measure CsA metabolites in biologic fluids, new questions include 'do CsA metabolites contribute significantly to either immunosuppression or renal toxicity?' Or, 'what is the role of the newly introduced immunoassays?' It is encouraging to note the continued interest in CsA pharmacology. It is hoped that present and future studies will provide answers to some of these questions.",
author = "Yee, {Gary C} and T. Rosano and R. Ptachcinski",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "20",
pages = "715--721",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "2 SUPPL. 2",

}

TY - JOUR

T1 - Pharmacology

T2 - Profiles, parameters, interpretations, and drug interactions

AU - Yee, Gary C

AU - Rosano, T.

AU - Ptachcinski, R.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Although knowledge concerning CsA pharmacology has expanded since the last CsA Congress in 1983, many of the same questions remain and many new questions are being asked. Examples of the questions that have not been answered include 'what is the most appropriate biologic fluid (whole blood v serum/plasma) or assay method (HPLC v RIA) for monitoring CsA concentration?' With the advent of HPLC assays that can measure CsA metabolites in biologic fluids, new questions include 'do CsA metabolites contribute significantly to either immunosuppression or renal toxicity?' Or, 'what is the role of the newly introduced immunoassays?' It is encouraging to note the continued interest in CsA pharmacology. It is hoped that present and future studies will provide answers to some of these questions.

AB - Although knowledge concerning CsA pharmacology has expanded since the last CsA Congress in 1983, many of the same questions remain and many new questions are being asked. Examples of the questions that have not been answered include 'what is the most appropriate biologic fluid (whole blood v serum/plasma) or assay method (HPLC v RIA) for monitoring CsA concentration?' With the advent of HPLC assays that can measure CsA metabolites in biologic fluids, new questions include 'do CsA metabolites contribute significantly to either immunosuppression or renal toxicity?' Or, 'what is the role of the newly introduced immunoassays?' It is encouraging to note the continued interest in CsA pharmacology. It is hoped that present and future studies will provide answers to some of these questions.

UR - http://www.scopus.com/inward/record.url?scp=0023945128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023945128&partnerID=8YFLogxK

M3 - Review article

VL - 20

SP - 715

EP - 721

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 2 SUPPL. 2

ER -